May 1st, 2012
With so many different interpretations to coding rules, your practice can’t afford not to create one. By Pam Brooks, CPC If coding were described as a color, it would be gray. Even with CPT®, ICD-9-CM, and HCPCS Level II guidelines, and despite regulatory guidance from the Centers for Medicare & Medicaid Services (CMS), the Office ...
In Billing
Jun 11th, 2010
Medicare does not allow for separate payment of Heparin when used to facilitate a flush during or following a drug infusion; nor should a separate administration code be billed for providing the heparin. To reduce the number of inappropriate paid claims received for this service, TrailBlazer Health Enterprises posted a June 10 notice on its ...
Jun 11th, 2010
Where there were two U.S. drug manufacturers of the popular sedative drug propofol, now there are none. Teva Pharmaceuticals Industries announced May 28 that it would continue to market its current supply but would make no more of the anesthetic. Hospira Inc. suspended production of the drug last month. Both companies have dealt with a multitude of propofol-related manufacturing ...
Oct 5th, 2009
The Food and Drug Administration (FDA) advised health care professionals Oct. 1 that a new version of heparin due to start shipping Oct. 8 is 10 percent less potent, and that this reduced potency could weaken its ability to prevent blood clots. Health Alert: New Heparin Less Potent was last modified: July 5th, 2011 by admin aapc...
In Coding
Nov 18th, 2008
The U.S. Food and Drug Administration (FDA) seized 11 lots of contaminated heparin—a blood thinner drug—from Celsus Laboratories Inc. on Nov. 6, according to an FDA news release. The 11 lots consisted of five lots of Heparin Sodium Active Pharmaceutical Ingredient (API) and six lots of Heparin Lithium. These products were manufactured in China and ...